Tag: COVID-19

Momentum of COVID-19 vaccine manufacturing scale up sufficient for step change in distribution
IFPMA Statement at the 11th APEC High-level Meeting on Health and the Economy - Session title: Incorporating Health Equity into Trade and Supply Chains for Vaccines and Medical Products
IFPMA Statement at the 71st session of the WHO Regional Committee for Africa: Special Event on the COVID-19 Response in the WHO AFRO Region
IFPMA Statement at WTO-WHO High Level Dialogue “Expanding COVID-19 Vaccine Manufacture to Promote Equitable Access” – Session title: Looking ahead
COVAX launches Marketplace to match buyers and sellers of critical manufacturing suppliers and speed up global access to COVID-19 vaccines through COVAX
ACT-Accelerator 1-Year Anniversary: the biopharmaceutical industry is committed to continue to play a critical role across ACT-A and accelerate equitable and fair access to COVID-19 tools
BIO-DCVMN-IFPMA COVID-19 Press Briefing - 23 April 2021 (Video)
COVID-19 vaccine industry cautions immediate action needed to remove manufacturing supply barriers to meet production targets and keep on course to equitable and fair access to COVID-19 vaccines
IFPMA statement at WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”
Pharma delivers COVID-19 solutions, but calls for the dilution of intellectual property rights are counterproductive
Innovative and generic & biosimilar pharmaceutical industries unite on commitment to equitable access to COVID-19 medicines and vaccines, while flagging where further help is needed from others
IFPMA/IGBA “Considerations on equitable access to COVID-19 medicines and vaccines”
IFPMA statement on “Intellectual Property and COVID-19”
IFPMA Statement for the Special session of the Executive Board on implementation of Resolution WHA73.1
5 lessons as COVID-19 unfolds for future pandemics – Insights from the biopharmaceutical industry
WHO PAHO 72nd Regional Committee: COVID-19 Pandemic in the Region of the Americas
Innovative health industries united in welcoming UNGA Resolution on “Comprehensive and Coordinated Response to the COVID-19 Pandemic”
Innovative vaccine and medicine industry applaud country commitments to COVAX Facility
IFPMA Statement on the G-FINDER Report “Landscape of Emerging Infectious Disease R&D: Preventing the Next Pandemic”
Thomas Cueni at the New World Model Virtual Event 2020 organized by WFZO
IFPMA Statement to G20 Health and Finance Ministers
Safety of vaccinated individuals is the top priority in development of COVID-19 vaccines
WHO EURO 70th Regional Committe: The response to the COVID-19 pandemic and lessons learned
Joint Guidance on Virtual International Medical Congresses Impacted by COVID-19
Global Biopharma CEO/Top Executives COVID-19 Media Briefing – COVID-19 therapeutics-3 September 2020 (Video)
Biopharma industry updates on COVID-19 treatments progress and warns about upholding regulatory standards of quality
WHO AFRO 70th REGIONAL MEETING Agenda item: 6 “Special event on the COVID-19 response in the WHO African Region”

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers